ilomastat has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Liu, MM; Peng, P; Song, J; Sun, X; Yu, JM; Zhou, L | 1 |
| Graessel, S; Ludwig, T; Oberleithner, H; Ossig, R; Schneider, SW; Wilhelmi, M | 1 |
2 other study(ies) available for ilomastat and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.
Topics: Anilides; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Hydrogen Bonding; Hydroxamic Acids; Indoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Molecular Docking Simulation; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Rats, Sprague-Dawley | 2016 |
The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion.
Topics: Animals; Basement Membrane; Cell-Free System; Coculture Techniques; Collagenases; Electric Impedance; Exocytosis; Humans; Hydroxamic Acids; Indoles; Kidney; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Melanoma; Neoplasm Invasiveness; Protease Inhibitors; Tumor Cells, Cultured | 2002 |